Share

February 2014; 4 (1) Clinical and Ethical Challenges

Osteoporosis for the practicing neurologist

Micol S. Rothman, Sterling G. West, Michael T. McDermott
First published November 13, 2013, DOI: https://doi.org/10.1212/01.CPJ.0000437349.39987.fa
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
203

Share

Article Information

vol. 4 no. 1 34-43
DOI: 
https://doi.org/10.1212/01.CPJ.0000437349.39987.fa
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • First Published November 13, 2013.

Article Versions

Copyright & Usage: 
© 2014 American Academy of Neurology

Author Disclosures

    1. Micol S. Rothman, MD,
    2. Sterling G. West, MD and
    3. Michael T. McDermott, MD
  1. Micol S. Rothman, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Sterling G. West, MD and
    3. Scientific Advisory Boards:

    1. I am Chair of the DMC for the trials looking at an antibody against IL-17 for treatment of psoriasis. This is an Amgen-sponsored trial. It has nothing to do with osteoporosis. Amgen makes denosumab which is mentioned in this review article.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. I own Novartis stock.They make zolendronic acid (reclast) which is mentioned in this review article.

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Michael T. McDermott, MD
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Department of Medicine-Endocrinology (MSR, MTM) and Department of Medicine-Rheumatology (SGW), University of Colorado School of Medicine, Denver, CO.
  1. Correspondence to:
    Micol.Rothman{at}ucdenver.edu
View Full Text

Article usage

Article usage: November 2013 to June 2022

AbstractFullPdfSource
Nov 20136407Highwire
Dec 20137003Highwire
Jan 20144204Highwire
Feb 20143922236Highwire
Mar 2014579733Highwire
Apr 20143571324Highwire
May 201419425Highwire
Jun 2014179916Highwire
Jul 20145822Highwire
Aug 20147507Highwire
Sep 20146604Highwire
Oct 20144501Highwire
Nov 20143051Highwire
Dec 20142411Highwire
Jan 20152301Highwire
Feb 20154000Highwire
Mar 20154813Highwire
Apr 20152704Highwire
May 20151202Highwire
Jun 20151500Highwire
Jul 20151500Highwire
Aug 20151340Highwire
Sep 20152201Highwire
Oct 20151300Highwire
Nov 20152804Highwire
Dec 20151500Highwire
Jan 20162201Highwire
Feb 20161801Highwire
Mar 20163701Highwire
Apr 20161601Highwire
May 20163500Highwire
Jun 20162404Highwire
Jul 20163000Highwire
Aug 20163700Highwire
Sep 20163810Highwire
Oct 20162900Highwire
Nov 20162701Highwire
Dec 20162600Highwire
Jan 20173110Highwire
Feb 20173211Highwire
Mar 20171800Highwire
Apr 20171900Highwire
May 20172500Highwire
Jun 20172800Highwire
Jul 20172400Highwire
Aug 20172200Highwire
Sep 20172201Highwire
Oct 20171900Highwire
Nov 20171700Highwire
Dec 20172010Highwire
Jan 20182100Highwire
Feb 20183241Highwire
Mar 20182112Highwire
Apr 20182922Highwire
Apr 2018110pmc
May 20184501Highwire
Jun 20183911Highwire
Jun 2018142pmc
Jul 20182602Highwire
Aug 20182300Highwire
Aug 2018199pmc
Sep 2018901Highwire
Oct 20181200Highwire
Nov 20182110Highwire
Dec 20182700Highwire
Jan 20192900Highwire
Feb 20192300Highwire
Mar 20192520Highwire
Apr 20192020Highwire
May 20192720Highwire
Jun 20191510Highwire
Jul 20192901Highwire
Aug 20191400Highwire
Sep 20191410Highwire
Oct 2019911Highwire
Nov 20191411Highwire
Dec 20191711Highwire
Jan 20201421Highwire
Feb 20201911Highwire
Mar 20201122Highwire
Apr 2020100Highwire
May 2020400Highwire
Jun 2020221Highwire
Jul 2020901Highwire
Aug 2020500Highwire
Sep 20201000Highwire
Oct 20202300Highwire
Nov 2020700Highwire
Dec 2020610Highwire
Jan 2021821Highwire
Feb 20211610Highwire
Mar 20213310Highwire
Apr 20211200Highwire
May 20212110Highwire
Jun 2021910Highwire
Jul 20212920Highwire
Aug 20213340Highwire
Sep 20211200Highwire
Oct 20211420Highwire
Nov 20211100Highwire
Dec 2021401Highwire
Jan 20221800Highwire
Feb 20222600Highwire
Mar 20221710Highwire
Apr 2022600Highwire
May 2022600Highwire
Jun 2022700Highwire

The Nerve!: Rapid online correspondence

Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me